Empty capsules found, Aurobindo Pharma recalls Gabapentin

by Anubha Sinha on  November 26, 2014 at 2:00 AM Drug News
RSS Email Print This Page Comment
Font : A-A+

After finding out that one lot of Gabapentin Capsules 300 mg had empty capsules, Aurobindo Pharma, US, has recalled the lot.
Empty capsules found, Aurobindo Pharma recalls Gabapentin
Empty capsules found, Aurobindo Pharma recalls Gabapentin

"Empty capsules could result in missed dose(s) of Gabapentin resulting in adverse health consequences that could range from no effect, short-term reduction in efficacy, short-term withdrawal effect, or status epilepticus (long period seizures) that could be life-threatening,'' the US Food and Drug Administration (USFDA) said in a release on its Web site.

The product was distributed under the Northstar label to retail outlets. Though no case of adverse event has been reported, four complaints of empty capsules have been received.

"Consumers, distributors, and retailers that have product which is being recalled should stop using, distributing, or dispensing the affected lot and return to place of purchase," the company advises.

Gabapentin is used for the treatment of epilepsy and manage postherpetic neuralgia.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive